BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29116209)

  • 1. Preoperative N-terminal pro-B-type natriuretic peptide concertation and prognosis of brain tumor patients: a 5-year follow up study.
    Bunevicius A; Deltuva V; Laws ER; Iervasi G; Tamsauskas A; Bunevicius R
    Sci Rep; 2017 Nov; 7(1):14775. PubMed ID: 29116209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Biological Correlates of Preoperative Cognitive Functioning of Glioma and Meningioma Patients.
    Pranckeviciene A; Deltuva VP; Tamasauskas A; Zegliene J; Bunevicius A
    Biomed Res Int; 2020; 2020():2054859. PubMed ID: 32461966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke.
    Bunevicius A; Kazlauskas H; Raskauskiene N; Mickuviene N; Ndreu R; Corsano E; Bunevicius R
    Neuroimmunomodulation; 2015; 22(6):365-72. PubMed ID: 25967464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.
    Bunevicius A; Deltuva VP; Tamasauskas S; Smith T; Laws ER; Bunevicius R; Iervasi G; Tamasauskas A
    Oncotarget; 2017 Jan; 8(5):8648-8656. PubMed ID: 28055959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
    Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
    Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The predictive value of plasma N-terminal pro-B-type natriuretic peptide levels in the evaluation of prognosis and the severity of patients with septic shock induced myocardial suppression].
    Chen W; Zhao L; Liu P; Sheng B; Zhen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):40-4. PubMed ID: 23611096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
    Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
    J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery?
    Ushirozako H; Ohishi T; Fujita T; Suzuki D; Yamamoto K; Banno T; Takase H; Matsuyama Y
    Clin Orthop Relat Res; 2017 Jun; 475(6):1730-1736. PubMed ID: 28101755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.
    Mueller T; Dieplinger B; Poelz W; Endler G; Wagner OF; Haltmayer M
    Clin Chem; 2009 Jan; 55(1):68-77. PubMed ID: 18988753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative brain natriuretic peptide predicts late mortality and functional class but not hospital readmission after cardiac surgery.
    Vikholm P; Schiller P; Hellgren L
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):520-7. PubMed ID: 24731743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [N-terminal pro-B-type natriuretic peptide value for prediction of mortality among critically ill patients in different age groups in intensive care unit].
    Li H; Wang H; Lou Y; Miao W; Sha N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):508-12. PubMed ID: 25027431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
    Bettencourt P; Azevedo A; Pimenta J; Friões F; Ferreira S; Ferreira A
    Circulation; 2004 Oct; 110(15):2168-74. PubMed ID: 15451800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
    J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery.
    Farzi S; Stojakovic T; Marko T; Sankin C; Rehak P; Gumpert R; Baumann A; Höfler B; Metzler H; Mahla E
    Br J Anaesth; 2013 Apr; 110(4):554-60. PubMed ID: 23248094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.